Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Forecasted Expansion Rate of the Acute Renal Failure (ARF) Market Over the 2025–2034 Period?

The market size for acute renal failure (ARF) has seen a robust expansion in recent times. It is projected to surge from a valuation of $6.09 billion in 2024 to around $6.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.6%. The notable growth in the historic phase can be credited to multiple factors such as the increasing elderly population, a higher number of sepsis cases, advancements in diagnostic techniques, government initiatives in healthcare, as well as a rise in nephrotoxic medication case occurrences.

Anticipated to witness substantial growth in the coming years, the acute renal failure (ARF) market is expected to reach $9.09 billion by 2029, progressing at a compound annual growth rate (CAGR) of 8.3%. The predicted expansion during the forecasted period can be ascribed to the broadening of home-based dialysis solutions, emerging markets, the advent of renal biomarkers, extensive research and development for new therapeutic drugs, and the surging necessity for non-invasive diagnostics. Key trends forecasted for the period include the advancement in continuous renal replacement therapy (CRRT), 3D bioprinting of renal tissue, the introduction of wearable biosensors, next-gen dialysis machines, and drug delivery fuelled by nanotechnology.

Which Primary Drivers Are Supporting the Continued Expansion of the Acute Renal Failure (ARF) Market?

The growth of the acute renal failure (ARF) market is anticipated to be fuelled by the rising incidence of chronic kidney diseases. Chronic kidney disease (CKD), a long-lasting ailment where the kidneys fail to properly filter the blood, is becoming increasingly prevalent due to escalating diabetes, hypertension, obesity, aging populations, and lifestyle-related factors globally. Acting as a substantial catalyst or exacerbating element for chronic kidney disease, acute renal failure, marked by the unexpected loss of kidney functionality, can cause irreversible harm to kidney tissues, compromise filtration efficacy, and augment the likelihood of continuous, long-term kidney malfunction, if not adequately controlled. For example, by June 2023, as per the report by Kidney Research UK, a non-profit association based in the UK, roughly 7.2 million residents of the UK are presently dealing with chronic kidney disease, accounting for over 10% of the population. Out of these, 3.25 million are in the advanced stages of the ailment, while a further 3.9 million are in the beginning stages. By 2033, it anticipates that the tally of individuals afflicted by chronic kidney disease will increase to 7.61 million. Consequently, the rising incidence of chronic kidney diseases is instigating the surge in the acute renal failure (ARF) market.

Explore Comprehensive Insights Into The Global Acute Renal Failure (ARF) Market With A Free Sample Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21083&type=smp

Who Are the Leading Organizations Fueling the Expansion of the Acute Renal Failure (ARF) Market?

Major companies operating in the acute renal failure (ARF) market are Pfizer Inc., Novartis AG, LG Chem Ltd., Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Baxter International Inc., Astellas Pharma Inc., Syensqo, Dr. Reddy’s Laboratories Limited, Zydus Lifesciences Limited, NIKKISO Co., Ltd., Quark Pharmaceuticals Inc., NIPRO Corporation, Alloksys Life Sciences B.V., AM-Pharma B.V., Sentien Biotechnologies, MediBeacon LLC, Angion Biomedica Corp., Atox Bio Ltd.

Which Cutting-Edge Trends Are Expected to Drive the Acute Renal Failure (ARF) Market’s Growth?

Principal businesses in the acute renal failure (ARF) market are working to acquire regulatory endorsements for medications to broaden their accessibility and consolidate their standing in treating severe acute kidney injury (AKI). These endorsements necessitate official permission from government or regulatory agencies for the public sale and use of drugs, medical equipment, or treatments. For example, CalciMedica., a clinical-stage biopharmaceutical company based in the US, earned FDA approval for an IND application for a Phase 2 trial of Auxora in February 2024, aiming to determine Auxora’s effectiveness in addressing severe acute kidney injury (AKI) linked with acute hypoxemic respiratory failure (AHRF), a condition known for its high fatality rate. The KOURAGE trial, a randomized, double-blind, placebo-controlled study, intends to enrol around 150 patients with Stage 2 and 3 acute kidney injury (AKI) who also experience acute hypoxemic respiratory failure (AHRF). The study aims to evaluate the effectiveness of Auxora through five daily doses by measuring the number of days patients live without the need for ventilators or dialysis up to 30 days following the treatment.

Secure Your Global Acute Renal Failure (ARF) Market Report Now for Fast and Efficient Delivery!

https://www.thebusinessresearchcompany.com/report/acute-renal-failure-arf-global-market-report

What Are the Key Components of the Acute Renal Failure (ARF) Market, and How Do Its Segments Perform?

The acute renal failure (ARF) market covered in this report is segmented –

1) By Disease Type: Prerenal Acute Renal Failure, Renal Acute Renal Failure, Postrenal Acute Renal Failure

2) By Drug Type: Diuretics, Vasopressors, Erythropoiesis-Stimulating Agents (ESAS), Phosphate Binders, Calcium and Vitamin D Supplements, Antibiotics, Others Drugs

3) By Route of Administration: Oral, Intravenous

4) By Diagnosis: Computed Tomography (CT) Scan, Kidney Biopsy, Ultrasound

5) By End-Users: Clinics, Hospitals, Home Healthcare, Others End-Users

Subsegments:

1) By Prerenal Acute Renal Failure: Hypovolemia, Decreased Cardiac Output, Renal Artery Stenosis

2) By Renal Acute Renal Failure: Acute Tubular Necrosis, Glomerulonephritis, Interstitial Nephritis

3) By Postrenal Acute Renal Failure: Obstructive Uropathy, Bladder Outlet Obstruction, Kidney Stones

Which Regions Are Most Influential in Expanding the Acute Renal Failure (ARF) Market?

North America was the largest region in the acute renal failure (ARF) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acute renal failure (ARF) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does the Definition of the Acute Renal Failure (ARF) Market Include?

Acute renal failure (ARF), also known as acute kidney injury (AKI), refers to a sudden and rapid decline in kidney function over a period of hours or days. Acute renal failure is treated through various methods, including medication, fluid management, and dialysis, to help restore kidney function and prevent further complications.

Browse Through More Similar Reports By The Business Research Company:

Hypolipidemics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypolipidemics-global-market-report

Hypophosphatasia Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hypophosphatasia-treatment-global-market-report

Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2025

https://thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: